Prostate News Archive
27-Mar-2007
Dendreon Corp: A Risky Proposition (SeekingAlpha via Yahoo! Finance)
Ant & Sons submits: On Friday, Dendreon Corp. shares gapped higher after TheStreet.com reporter Adam Feuerstein wrote in an article that if Dendreon gets approval for its prostate cancer vaccine Provenge, the stock would be worth about $27. Pomegranate Juice May be Good for the Prostate and Heart (Newswise)
Few American men have heard of the pomegranate, and fewer still have eaten this curious-looking fruit loaded with red seeds. But new scientific findings suggest that pomegranates may one day find a place in healthful diets, reports the April 2007 issue of Harvard Men's Health Watch. More Knowledge of Prostate Cancer Leads to Fewer Screenings (Newswise)
Patients given prostate cancer information prior to their medical examinations participated more actively in decision making and were less likely to opt for screening tests, according to a Virginia Commonwealth University study released today. American Urological Association Foundation and GOLF Magazine Team Up to Educate Men About Prostate Cancer (RedNova)
To: AND SPORTS EDITORS Contact: Wendy W
Back to Prostate News Archive
